Alissa Visram

Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients

Alissa Visram, Camilia Soof, S. Vincent Rajkumar et al. · Blood Cancer Journal · 2021 · 50 citations · Full text

Medicine, Hematology, Oncology +7

Relapsed multiple myeloma demonstrates distinct patterns of immune microenvironment and malignant cell-mediated immunosuppression

Alissa Visram, Surendra Dasari, Emilie Anderson et al. · Blood Cancer Journal · 2021 · 38 citations · Full text

Medicine, Immunology, Oncology +17

Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening

Alissa Visram, Kelvin Chan, Phyllis McGee et al. · PLoS ONE · 2015 · 37 citations · Full text

Medicine, Hematology, Oncology +11

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients

Abdullah S. Al Saleh, Harsh Parmar, Alissa Visram et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 33 citations · Full text

Medicine, Hematology, Oncology +12

Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota

Geffen Kleinstern, Dirk R. Larson, Cristine Allmer et al. · Blood Cancer Journal · 2022 · 32 citations · Full text

Medicine, Hematology, Internal Medicine +10